EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion

Alexandra Irene Ziegler; Regina Heidenreich; Heidi Braumuller; Hartwig Wolburg; Susanne Weidemann; Ralph Mocikat; Martin Rocken

doi:10.1182/blood-2008-08-175109

EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion

Alexandra Irene Ziegler, Regina Heidenreich, Heidi Braumuller, Hartwig Wolburg, Susanne Weidemann, Ralph Mocikat, Martin Rocken

Research output: Contribution to journal › Article › Research › peer-review

71 Citations (Scopus)

Abstract

Experimental tumor vaccination and adop-tive T-cell therapies show that interferon-I? (IFN-I?)-producing CD4+ T helper cells (Th1) can be highly effective in tumor prevention and therapy.

Original language	English
Pages (from-to)	3494 - 3502
Number of pages	9
Journal	Blood
Volume	113
Issue number	15
DOIs	https://doi.org/10.1182/blood-2008-08-175109
Publication status	Published - 2009
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1182/blood-2008-08-175109

Cite this

@article{4038fd88ea764b7f9c1df9b7bcb6de6b,

title = "EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion",

abstract = "Experimental tumor vaccination and adop-tive T-cell therapies show that interferon-I? (IFN-I?)-producing CD4+ T helper cells (Th1) can be highly effective in tumor prevention and therapy.",

author = "Ziegler, \{Alexandra Irene\} and Regina Heidenreich and Heidi Braumuller and Hartwig Wolburg and Susanne Weidemann and Ralph Mocikat and Martin Rocken",

year = "2009",

doi = "10.1182/blood-2008-08-175109",

language = "English",

volume = "113",

pages = "3494 -- 3502",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "15",

}

TY - JOUR

T1 - EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion

AU - Ziegler, Alexandra Irene

AU - Heidenreich, Regina

AU - Braumuller, Heidi

AU - Wolburg, Hartwig

AU - Weidemann, Susanne

AU - Mocikat, Ralph

AU - Rocken, Martin

PY - 2009

Y1 - 2009

N2 - Experimental tumor vaccination and adop-tive T-cell therapies show that interferon-I? (IFN-I?)-producing CD4+ T helper cells (Th1) can be highly effective in tumor prevention and therapy.

AB - Experimental tumor vaccination and adop-tive T-cell therapies show that interferon-I? (IFN-I?)-producing CD4+ T helper cells (Th1) can be highly effective in tumor prevention and therapy.

UR - http://bloodjournal.hematologylibrary.org.ezproxy.lib.monash.edu.au/content/113/15/3494

UR - https://www.scopus.com/pages/publications/65149083820

U2 - 10.1182/blood-2008-08-175109

DO - 10.1182/blood-2008-08-175109

M3 - Article

SN - 0006-4971

VL - 113

SP - 3494

EP - 3502

JO - Blood

JF - Blood

IS - 15

ER -

EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion

Abstract

UN SDGs

Access to Document

Other files and links

Cite this